US OptionsDetailed Quotes
GLUE241220P12500
- 0.00
- 0.000.00%
15min DelayTrading Nov 26 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest12.50Strike Price0.00Turnover121.58%IV-45.86%PremiumDec 20, 2024Expiry Date3.93Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8518Delta0.0890Gamma2.12Leverage Ratio-0.0118Theta-0.0055Rho-1.80Eff Leverage0.0051Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet